How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Close this folder2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contentsOrganization of the national formulary committee
View the documentAgreement on purpose, content, structure and format
View the documentFinancing
View the documentSelection of medicines to be included in the national formulary
View the documentDevelopment of the draft
View the documentReviewing and finalizing content
View the documentProduction, dissemination and implementation
View the documentEvaluation and review
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS

The development and maintenance of a NF is a dynamic process and requires careful planning and coordination. Widespread support of relevant government, professional and possibly health insurance organizations is vital. The major stages of the development and maintenance processes are illustrated in Figure 2.1.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014